Caricamento...
Gamma synchrony: towards a translational biomarker for the treatment resistant symptoms of schizophrenia
The lack of efficacy for antipsychotics with respect to negative symptoms and cognitive deficits is a significant obstacle for the treatment of schizophrenia. Developing new drugs to target these symptoms requires appropriate neural biomarkers that can be investigated in model organisms, be used to...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2011
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3264822/ https://ncbi.nlm.nih.gov/pubmed/21349276 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2011.02.007 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|